Business
fromLondon Business News | Londonlovesbusiness.com
5 days agoGSK to buy RAPT Therapeutics in $2.2 billion deal
GSK will acquire RAPT Therapeutics for $2.2 billion to strengthen its immunology and inflammation pipeline and gain RAPT's lead immune-targeting drug candidate.